Sodium and potassium changes during decongestion with acetazolamide–A pre‐specified analysis from the ADVOR trial

S Dhont, P Martens, E Meekers, J Dauw… - European Journal of …, 2023 - Wiley Online Library
Aims Acetazolamide, an inhibitor of proximal tubular sodium reabsorption, leads to more
effective decongestion in acute heart failure (AHF). It is unknown whether acetazolamide …

Sodium and potassium changes during decongestion with acetazolamide-A pre-specified analysis from the ADVOR trial

S Dhont, P Martens, E Meekers, J Dauw, FH Verbrugge… - 2023 - pubmed.ncbi.nlm.nih.gov
Aims Acetazolamide, an inhibitor of proximal tubular sodium reabsorption, leads to more
effective decongestion in acute heart failure (AHF). It is unknown whether acetazolamide …

Sodium and potassium changes during decongestion with acetazolamide-A pre-specified analysis from the ADVOR trial

S Dhont, P Martens, E Meekers, J Dauw… - European Journal of …, 2023 - zora.uzh.ch
AIMS: Acetazolamide, an inhibitor of proximal tubular sodium reabsorption, leads to more
effective decongestion in acute heart failure (AHF). It is unknown whether acetazolamide …

[PDF][PDF] Sodium and potassium changes during decongestion with acetazolamide–A pre-specified analysis from the ADVOR trial

S Dhont, P Martens, E Meekers, J Dauw… - European Journal of …, 2023 - research.rug.nl
Aims Acetazolamide, an inhibitor of proximal tubular sodium reabsorption, leads to more
effective decongestion in acute heart failure (AHF). It is unknown whether acetazolamide …

Sodium and potassium changes during decongestion with acetazolamide: A pre-specified analysis from the ADVOR trial

S Dhont, P Martens, E Meekers, J Dauw… - European Journal of …, 2023 - research.rug.nl
AIMS: Acetazolamide, an inhibitor of proximal tubular sodium reabsorption, leads to more
effective decongestion in acute heart failure (AHF). It is unknown whether acetazolamide …